Evaluation mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and Innovation to Generate Evidence for personalised care.
Start Date: 01/05/2015
Duration: 60 months
“In the EmERGE validation study the platform and application are currently being used by 2250 patients at five clinics in different countries throughout Europe.”
EmERGE has developed a mHealth platform to enable self-management of HIV in patients with stable disease. The project aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, with at least 2250 saved within the study alone.
How does it work?
The platform provides users with a mobile phone application which interfaces securely with relevant medical data and facilitates remote access to key healthcare providers. EATG, the European HIV patient organisation, are providing a direct and deep interaction with representative patients and clinicians. The platform builds upon and integrates the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and applies a rigorous co-design approach to ensure patient and clinician input to the solution.